DFTX
Definium Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD23.59
+0.73 (+3.19%)
Rating:C-
Company Profile
CEO
Robert Barrow
IPO Date
2016-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$22.75
Prev. Close
$22.86
Day Low
$22.29
Day High
$23.71
52W Low
$12.88
52W High
$26.15
Market Cap
$2.57B
Volume
2.29M